CRAIG MILLER: Open Payments
NPI 1659325397 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 36 payments from 16 companies in 2025. Trend: 2023 $750 · 2024 $560 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $153 |
| Medtronic, Inc. | 2 | $149 |
| Alnylam Pharmaceuticals Inc. | 6 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| CVRx, Inc. | 1 | $49 |
| Lilly USA, LLC | 2 | $37 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
Products named: Repatha, MICRA, ONPATTRO, LEQVIO, CAMZYOS, VERQUVO, Barostim Neo System, MOUNJARO.
Industry payments across NY — which companies pay providers there.
